Cargando…
Suggested risk factor for oral lichen planus arising after mRNA COVID‐19 vaccination
A single dose of BNT162b2 vaccine is suggested for COVID‐19‐infected individuals to reduce side effects due to release of inflammatory mediators such as oral lichen planus (OLP).
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307884/ https://www.ncbi.nlm.nih.gov/pubmed/35898746 http://dx.doi.org/10.1002/ccr3.6126 |
_version_ | 1784752860743860224 |
---|---|
author | Zargaran, Massoumeh |
author_facet | Zargaran, Massoumeh |
author_sort | Zargaran, Massoumeh |
collection | PubMed |
description | A single dose of BNT162b2 vaccine is suggested for COVID‐19‐infected individuals to reduce side effects due to release of inflammatory mediators such as oral lichen planus (OLP). |
format | Online Article Text |
id | pubmed-9307884 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93078842022-07-26 Suggested risk factor for oral lichen planus arising after mRNA COVID‐19 vaccination Zargaran, Massoumeh Clin Case Rep Editorial A single dose of BNT162b2 vaccine is suggested for COVID‐19‐infected individuals to reduce side effects due to release of inflammatory mediators such as oral lichen planus (OLP). John Wiley and Sons Inc. 2022-07-22 /pmc/articles/PMC9307884/ /pubmed/35898746 http://dx.doi.org/10.1002/ccr3.6126 Text en © 2022 The Author. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Editorial Zargaran, Massoumeh Suggested risk factor for oral lichen planus arising after mRNA COVID‐19 vaccination |
title | Suggested risk factor for oral lichen planus arising after mRNA COVID‐19 vaccination |
title_full | Suggested risk factor for oral lichen planus arising after mRNA COVID‐19 vaccination |
title_fullStr | Suggested risk factor for oral lichen planus arising after mRNA COVID‐19 vaccination |
title_full_unstemmed | Suggested risk factor for oral lichen planus arising after mRNA COVID‐19 vaccination |
title_short | Suggested risk factor for oral lichen planus arising after mRNA COVID‐19 vaccination |
title_sort | suggested risk factor for oral lichen planus arising after mrna covid‐19 vaccination |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307884/ https://www.ncbi.nlm.nih.gov/pubmed/35898746 http://dx.doi.org/10.1002/ccr3.6126 |
work_keys_str_mv | AT zargaranmassoumeh suggestedriskfactorfororallichenplanusarisingaftermrnacovid19vaccination |